SCHEMBL5815317

SCHEMBL5815317

NC(C(=O)O)C(=O)c1nc(Sc2ccc(Cl)cc2)c2ccccc2c1O

nearest known ligand 0.46

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 2/20 0.46
MEN1 O00255 1/20 0.43
CRHBP P24387 1/20 0.43
KMT2A Q03164 1/20 0.43
CRHR2 Q13324 1/20 0.43
HAO1 Q9UJM8 1/20 0.40
MAPT P10636 2/20 0.40
TP53 P04637 1/20 0.40
EGLN1 Q9GZT9 5/20 0.39
FTO Q9C0B1 4/20 0.39
BBOX1 O75936 3/20 0.39
XBP1 P17861 1/20 0.36
HTT P42858 1/20 0.36
SMN1; SMN2 Q16637 1/20 0.36
NPSR1 Q6W5P4 1/20 0.36
FLT1 P17948 1/20 0.36
KDR P35968 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5141913 0.91 ABCG2 (0.41) KDM4EMEN1KMT2AMAPTEGLN1
SCHEMBL522232 0.80 EGLN1 (0.66) KDM4EMEN1CRHBPKMT2ACRHR2
SCHEMBL523578 0.80 EGLN1 (0.66) KDM4EMEN1CRHBPKMT2ACRHR2
SCHEMBL522233 0.80 EGLN1 (0.66) KDM4EMEN1CRHBPKMT2ACRHR2
SCHEMBL5934945 0.78 EGLN1 (0.43) EGLN1FTOBBOX1
SCHEMBL30274512 0.77 EGLN1 (0.66) KDM4EEGLN1FTOBBOX1
SCHEMBL4755914 0.76 EGLN1 (0.65) KDM4EEGLN1FTOBBOX1
SCHEMBL1076121 0.73 EGLN1 (0.43) MAPTTP53EGLN1FTOBBOX1
SCHEMBL2354419 0.69 THRB (0.43) EGLN1FTOBBOX1
SCHEMBL521900 0.67 EGLN1 (0.66) EGLN1FTOBBOX1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-116018136-A Hypoxia-inducible factor prolyl hydroxylase inhibitors for the treatment of aging-related disorders 百爱及生物医药公司 2023-04-25 CN disclosed
WO-2006099610-A2 METHODS OF IDENTIFYING THERAPEUTIC TARGETS FOR THE TREATMENT OF VULVOVAGINAL ATROPHY WYETH (US) 2006-09-21 WO disclosed